These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 26861120)
1. Setting priorities in health research using the model proposed by the World Health Organization: development of a quantitative methodology using tuberculosis in South Africa as a worked example. Hacking D; Cleary S Health Res Policy Syst; 2016 Feb; 14():10. PubMed ID: 26861120 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness analysis of strategies for tuberculosis control in developing countries. Baltussen R; Floyd K; Dye C BMJ; 2005 Dec; 331(7529):1364. PubMed ID: 16282379 [TBL] [Abstract][Full Text] [Related]
3. The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa. Knight GM; Gomez GB; Dodd PJ; Dowdy D; Zwerling A; Wells WA; Cobelens F; Vassall A; White RG PLoS One; 2015; 10(12):e0145796. PubMed ID: 26717007 [TBL] [Abstract][Full Text] [Related]
4. Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries. Lu X; Smare C; Kambili C; El Khoury AC; Wolfson LJ BMC Health Serv Res; 2017 Jan; 17(1):87. PubMed ID: 28122562 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Marx FM; Cohen T; Menzies NA; Salomon JA; Theron G; Yaesoubi R Lancet Glob Health; 2020 Sep; 8(9):e1223-e1233. PubMed ID: 32827484 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251 [TBL] [Abstract][Full Text] [Related]
7. Estimating a cost-effectiveness threshold for health care decision-making in South Africa. Edoka IP; Stacey NK Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375 [TBL] [Abstract][Full Text] [Related]
8. Strengthening tuberculosis control overseas: who benefits? Nguyen HT; Hickson RI; Kompas T; Mercer GN; Lokuge KM Value Health; 2015 Mar; 18(2):180-8. PubMed ID: 25773553 [TBL] [Abstract][Full Text] [Related]
9. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Dowdy DW; O'Brien MA; Bishai D Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499 [TBL] [Abstract][Full Text] [Related]
11. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749 [TBL] [Abstract][Full Text] [Related]
12. Using epidemiological data to model efficiency in reducing the burden of depression*. Andrews G; Sanderson K; Corry J; Lapsley HM J Ment Health Policy Econ; 2000 Dec; 3(4):175-186. PubMed ID: 11967454 [TBL] [Abstract][Full Text] [Related]
13. Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis. Basu S; Wagner RG; Sewpaul R; Reddy P; Davies J Lancet Glob Health; 2019 Feb; 7(2):e270-e280. PubMed ID: 30528531 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721 [TBL] [Abstract][Full Text] [Related]
15. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India. Azman AS; Golub JE; Dowdy DW BMC Med; 2014 Oct; 12():216. PubMed ID: 25358459 [TBL] [Abstract][Full Text] [Related]
16. Costs and benefits of neurosurgical intervention for infant hydrocephalus in sub-Saharan Africa. Warf BC; Alkire BC; Bhai S; Hughes C; Schiff SJ; Vincent JR; Meara JG J Neurosurg Pediatr; 2011 Nov; 8(5):509-21. PubMed ID: 22044378 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa. Cleary SM; Wilkinson T; Tamandjou Tchuem CR; Docrat S; Solanki GC BMC Health Serv Res; 2021 Jan; 21(1):82. PubMed ID: 33482807 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of the Health X Project for tuberculosis control in China. Wang WB; Zhang H; Petzold M; Zhao Q; Xu B; Zhao GM Int J Tuberc Lung Dis; 2014 Aug; 18(8):939-45. PubMed ID: 25199008 [TBL] [Abstract][Full Text] [Related]
19. Drones and digital adherence monitoring for community-based tuberculosis control in remote Madagascar: A cost-effectiveness analysis. Bahrainwala L; Knoblauch AM; Andriamiadanarivo A; Diab MM; McKinney J; Small PM; Kahn JG; Fair E; Rakotosamimanana N; Grandjean Lapierre S PLoS One; 2020; 15(7):e0235572. PubMed ID: 32634140 [TBL] [Abstract][Full Text] [Related]
20. Global burden of disease in young people aged 10-24 years: a systematic analysis. Gore FM; Bloem PJ; Patton GC; Ferguson J; Joseph V; Coffey C; Sawyer SM; Mathers CD Lancet; 2011 Jun; 377(9783):2093-102. PubMed ID: 21652063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]